Shine-On Bio
聖安生醫股份有限公司
Shine-On Bio is a Taiwan Emerging Stock Board biotechnology company; its most advanced asset is SOB100 (Phase 1; recruiting, Healthy Subjects; Exosome; Targeted Therapy), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| SOB100 | — | Phase 1; recruiting | Healthy Subjects; Exosome; Targeted Therapy | United States | 2026-01-26 | Trial registry |
| SOA101 | — | — | — | — | 2025-06-03 | Company disclosure |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.